TABLE 3.
Site | Max size (cm) |
Margin status |
Grade | RT | CT | Time to first local recurrence (mo) |
No. of local recurrences |
Distant metastatic disease |
Treatment of local recurrence | Status |
---|---|---|---|---|---|---|---|---|---|---|
UE-P | 10 | <1 mm | 3 | Pre | – | 13 | 3 | – | (1) EBRT/resection/brachytherapy, (2) resection, (3) amputation |
DOD |
LE-P | 15.5 | >1 mm | 3 | Pre | Pre/post | 16 | 1 | Lung | Resection | DOD |
LE-P | 2.2 | >1 mm | 3 | Pre/post | Post | 45 | 1 | Lung, brain | Resection | DOD |
LE-P | 10.5 | Positive | 3 | Pre/post | – | 36 | 2 | Lung | (1) Resection + IORT, (2) amputation | DOD |
Trunk | 10 | <1 mm | 2 | Pre/IORT | – | 10 | 1 | – | Open biopsy only | DOD |
Breast | 7 | >1 mm | 3 | – | – | 17 | 1 | – | Resection/EBRT | NED |
UE-D | 2.5 | Positive | 3 | – | – | 6 | 1 | – | Resection/brachytherapy | NED |
UE-D (R) | 5.5 | Positive | 2 | – | – | 12 | 2 | – | (1) Resection, (2) amputation | DOD |
LE-P (R) | 2 | Positive | 3 | – | – | 85 | 3 | – | (1) EBRT/resection/boost, (2) resection/ brachytherapy, (3) resection |
NED |
LE-D | 1.5 | <1 mm | 2 | – | – | 8 | 1 | – | EBRT/resection | NED |
Trunk | 6 | Positive | 3 | Pre/post | – | 35 | 1 | – | EBRT only | NED |
RT radiotherapy, CT chemotherapy, Pre/Post sequencing with surgery (before or after), UE-P upper extremity—proximal, UE-D upper extremity—distal, LE-P lower extremity—proximal, LE-D lower extremity—distal, (R) recurrent tumor, IORT intraoperative radiotherapy, EBRT external-beam radiotherapy, DOD dead of disease, NED no evidence of disease